Vor Biopharma Inc. (NASDAQ:VOR – Free Report) – HC Wainwright cut their FY2030 earnings per share (EPS) estimates for Vor Biopharma in a research note issued to investors on Wednesday, August 12th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of $3.89 per share for the year, down from their […]

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR – Free Report) – HC Wainwright lowered their Q3 2026 EPS estimates for shares of Pharming Group in a report issued on Thursday, July 30th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of $0.20 for the quarter, down from their previous […]